세계의 생물 안전 캐비닛 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Biological Safety Cabinet Market is presumed to reach the market size of nearly USD 492.51 Million by 2032 from USD 245.56 Million in 2023 with a CAGR of 8.04% under the study period 2024-2032.

A biological safety cabinet (BSC) is a ventilated laboratory workspace designed to protect users, samples, and the environment from biohazardous or infectious agents. BSCs use high-efficiency particulate air (HEPA) filters to capture and contain airborne contaminants, providing a sterile environment for conducting microbiological and biomedical procedures. There are different classes of BSCs (I, II, III), each offering varying levels of protection and containment. These cabinets are essential in research, clinical, and pharmaceutical laboratories, ensuring safety and compliance with biosafety regulations.

MARKET DYNAMICS

The biological safety cabinet market is driven by the rising incidence of infectious diseases and the consequent rise in drug development and testing research activities. Biological safety cabinets are essential for maintaining laboratory safety standards, which is crucial as governments and private sectors invest heavily in healthcare infrastructure. The stringent regulations set by health and safety authorities worldwide necessitate using these cabinets, thereby boosting market demand. Moreover, technological progress has resulted in the development of more efficient and user-friendly biological safety cabinets, enhancing their adoption. The growing focus on biosafety and the increasing number of biosafety laboratories, particularly in emerging economies, also contribute to the market growth. Additionally, the expanding biotechnology and pharmaceutical industries are significant drivers, as these sectors require high-standard laboratory equipment to ensure safe and effective research and production processes. However, high installation and maintenance costs may hinder market growth in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Biological Safety Cabinet. The growth and trends of Biological Safety Cabinet industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Biological Safety Cabinet market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Class I
• Class II (Class II Type A, Class II Type B)
• Class III

By End-Use

• Pharmaceutical & Biopharmaceutical Companies
• Diagnostics & Testing Laboratories
• Academic & Research Organizations

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Biological Safety Cabinet market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Biological Safety Cabinet market include Thermo Fisher Scientific Inc., Labconco Corp., NuAire Inc., The Baker Company Inc., AZBIL TELSTAR, S.L.U., Jinan Biobase Biotech Co. Ltd., Germfree Laboratories Inc., Air Science Inc., Haier Biomedical (Qingdao Biomedical Co. Ltd.), Cruma S.A. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. BIOLOGICAL SAFETY CABINET - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By End-Use
  • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BIOLOGICAL SAFETY CABINET MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. Class I Historic and Forecast Sales By Regions
• 5.4. Class II (Class II Type A, Class II Type B) Historic and Forecast Sales By Regions
• 5.5. Class III Historic and Forecast Sales By Regions

6. GLOBAL BIOLOGICAL SAFETY CABINET MARKET ANALYSIS BY END-USE

• 6.1. Overview By End-Use
• 6.2. Historical and Forecast Data Analysis By End-Use
• 6.3. Pharmaceutical & Biopharmaceutical Companies Historic and Forecast Sales By Regions
• 6.4. Diagnostics & Testing Laboratories Historic and Forecast Sales By Regions
• 6.5. Academic & Research Organizations Historic and Forecast Sales By Regions

7. GLOBAL BIOLOGICAL SAFETY CABINET MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2 North America By Segment Sales Analysis
  • 7.3.3 North America By Country Sales Analysis
  • 7.3.4 United States Sales Analysis
  • 7.3.5 Canada Sales Analysis
  • 7.3.6 Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2 Europe By Segment Sales Analysis
  • 7.4.3 Europe By Country Sales Analysis
  • 7.4.4 United Kingdom Sales Analysis
  • 7.4.5 France Sales Analysis
  • 7.4.6 Germany Sales Analysis
  • 7.4.7 Italy Sales Analysis
  • 7.4.8 Russia Sales Analysis
  • 7.4.9 Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2 Asia Pacific By Segment Sales Analysis
  • 7.5.3 Asia Pacific By Country Sales Analysis
  • 7.5.4 China Sales Analysis
  • 7.5.5 India Sales Analysis
  • 7.5.6 Japan Sales Analysis
  • 7.5.7 South Korea Sales Analysis
  • 7.5.8 Australia Sales Analysis
  • 7.5.9 South East Asia Sales Analysis
  • 7.5.10 Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2 Latin America By Segment Sales Analysis
  • 7.6.3 Latin America By Country Sales Analysis
  • 7.6.4 Brazil Sales Analysis
  • 7.6.5 Argentina Sales Analysis
  • 7.6.6 Peru Sales Analysis
  • 7.6.7 Chile Sales Analysis
  • 7.6.8 Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2 Middle East & Africa By Segment Sales Analysis
  • 7.7.3 Middle East & Africa By Country Sales Analysis
  • 7.7.4 Saudi Arabia Sales Analysis
  • 7.7.5 UAE Sales Analysis
  • 7.7.6 Israel Sales Analysis
  • 7.7.7 South Africa Sales Analysis
  • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE BIOLOGICAL SAFETY CABINET COMPANIES

• 8.1. Biological Safety Cabinet Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9. COMPANY PROFILES OF BIOLOGICAL SAFETY CABINET INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Thermo Fisher Scientific Inc.
  • 9.3.1 Company Overview
  • 9.3.2 Company Revenue
  • 9.3.3 Products
  • 9.3.4 Recent Developments
• 9.4. Labconco Corp.
  • 9.4.1 Company Overview
  • 9.4.2 Company Revenue
  • 9.4.3 Products
  • 9.4.4 Recent Developments
• 9.5. NuAire Inc.
  • 9.5.1 Company Overview
  • 9.5.2 Company Revenue
  • 9.5.3 Products
  • 9.5.4 Recent Developments
• 9.6. The Baker Company Inc.
  • 9.6.1 Company Overview
  • 9.6.2 Company Revenue
  • 9.6.3 Products
  • 9.6.4 Recent Developments
• 9.7. AZBIL TELSTAR
  • 9.7.1 Company Overview
  • 9.7.2 Company Revenue
  • 9.7.3 Products
  • 9.7.4 Recent Developments
• 9.8. S.L.U.
  • 9.8.1 Company Overview
  • 9.8.2 Company Revenue
  • 9.8.3 Products
  • 9.8.4 Recent Developments
• 9.9. Jinan Biobase Biotech Co. Ltd.
  • 9.9.1 Company Overview
  • 9.9.2 Company Revenue
  • 9.9.3 Products
  • 9.9.4 Recent Developments
• 9.10. Germfree Laboratories Inc.
  • 9.10.1 Company Overview
  • 9.10.2 Company Revenue
  • 9.10.3 Products
  • 9.10.4 Recent Developments
• 9.11. Air Science Inc.
  • 9.11.1 Company Overview
  • 9.11.2 Company Revenue
  • 9.11.3 Products
  • 9.11.4 Recent Developments
• 9.12. Haier Biomedical (Qingdao Biomedical Co. Ltd.)
  • 9.12.1 Company Overview
  • 9.12.2 Company Revenue
  • 9.12.3 Products
  • 9.12.4 Recent Developments
• 9.13. Cruma S.A
  • 9.13.1 Company Overview
  • 9.13.2 Company Revenue
  • 9.13.3 Products
  • 9.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies